Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and ca125 in predicting epithelial ovarian cancer: A meta-analysis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and ca125 in predicting epithelial ovarian cancer: A meta-analysis
Authors
Keywords
-
Journal
BMC CANCER
Volume 12, Issue 1, Pages -
Publisher
Springer Nature
Online
2012-06-28
DOI
10.1186/1471-2407-12-258
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic Reviews of Diagnostic Test Accuracy
- (2013) Mariska M.G. Leeflang ANNALS OF INTERNAL MEDICINE
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
- (2013) Penny F. Whiting ANNALS OF INTERNAL MEDICINE
- Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta- analysis
- (2012) Ying Zhou et al. BMC CANCER
- Improved blood tests for cancer screening: general or specific?
- (2011) Ian A Cree BMC CANCER
- Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancer
- (2011) Renquan Lu et al. BMC CANCER
- HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
- (2011) T Van Gorp et al. BRITISH JOURNAL OF CANCER
- Serum Human Epididymis Protein 4 and Risk for Ovarian Malignancy Algorithm as New Diagnostic and Prognostic Tools for Epithelial Ovarian Cancer Management
- (2011) E. Bandiera et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Diagnostic performances of HE4 and CA125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseases
- (2011) Yongjung Park et al. CLINICAL BIOCHEMISTRY
- The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?
- (2011) Martina Montagnana et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting
- (2011) Francis Jacob et al. GYNECOLOGIC ONCOLOGY
- Human Epididymis Protein 4 (HE4) as a Serum Tumor Biomarker in Patients With Ovarian Carcinoma
- (2011) Xiaohong Chang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Evaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic Mass
- (2011) Richard G. Moore et al. OBSTETRICS AND GYNECOLOGY
- Human epididymis protein 4 reference limits and natural variation in a Nordic reference population
- (2011) Nils Bolstad et al. TUMOR BIOLOGY
- E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer
- (2010) Narasimhan Kothandaraman et al. BMC CANCER
- Development of a Multimarker Assay for Early Detection of Ovarian Cancer
- (2010) Zoya Yurkovetsky et al. JOURNAL OF CLINICAL ONCOLOGY
- When are summary ROC curves appropriate for diagnostic meta-analyses?
- (2009) F. M. Chappell et al. STATISTICS IN MEDICINE
- The Preclinical Natural History of Serous Ovarian Cancer: Defining the Target for Early Detection
- (2009) Patrick O. Brown et al. PLOS MEDICINE
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
- (2008) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
- The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
- (2007) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now